These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23681780)

  • 1. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores.
    Saad WE; Wagner CC; Al-Osaimi A; Bliebel W; Lippert A; Davies MG; Sabri SS; Turba UC; Matsumoto AH; Angle JF; Caldwell S
    Vasc Endovascular Surg; 2013 May; 47(4):281-7. PubMed ID: 23681780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO).
    Saad WE; Wagner CC; Lippert A; Al-Osaimi A; Davies MG; Matsumoto AH; Angle JF; Caldwell S
    Am J Gastroenterol; 2013 Oct; 108(10):1612-9. PubMed ID: 23939627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.
    Kim SK; Lee KA; Sauk S; Korenblat K
    Korean J Radiol; 2017; 18(2):345-354. PubMed ID: 28246514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction for Improvement of Liver Function after Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices to Manage Portosystemic Shunt Syndrome.
    Yamamoto A; Nishida N; Morikawa H; Jogo A; Kageyama K; Sohgawa E; Hamamoto S; Takeshita T; Sakai Y; Matsuoka T; Kawada N; Miki Y
    J Vasc Interv Radiol; 2016 Aug; 27(8):1160-7. PubMed ID: 27234486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balloon Retrograde Transvenous Obliteration Versus Endoscopic Cyanoacrylate in Bleeding Gastric Varices: Comparison of Rebleeding and Mortality with Extended Follow-up.
    Stein DJ; Salinas C; Sabri S; Onyeali R; Caldwell S; Henry Z
    J Vasc Interv Radiol; 2019 Feb; 30(2):187-194. PubMed ID: 30717949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications.
    Saad WE; Kitanosono T; Koizumi J; Hirota S
    Tech Vasc Interv Radiol; 2013 Jun; 16(2):101-51. PubMed ID: 23830671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon-occluded antegrade transvenous obliteration with or without balloon-occluded retrograde transvenous obliteration for the management of gastric varices: concept and technical applications.
    Saad WE; Kitanosono T; Koizumi J
    Tech Vasc Interv Radiol; 2012 Sep; 15(3):203-25. PubMed ID: 23021832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing logistics for balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices by doing away with the indwelling balloon: concept and techniques.
    Saad WE; Nicholson DB
    Tech Vasc Interv Radiol; 2013 Jun; 16(2):152-7. PubMed ID: 23830672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    Lee SJ; Kim SU; Kim MD; Kim YH; Kim GM; Park SI; Won JY; Lee DY; Lee KH
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1487-1494. PubMed ID: 28085232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices.
    Choi YS; Lee JH; Sinn DH; Song YB; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC
    J Clin Gastroenterol; 2008 Oct; 42(9):974-9. PubMed ID: 18528292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon-occluded retrograde transvenous obliteration for intractable gastric variceal bleeding.
    Liang TJ; Chen YC; Liang HL; Liu SI; Chang PM
    J Formos Med Assoc; 2013 Jul; 112(7):426-9. PubMed ID: 23927983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year outcomes of balloon-occluded retrograde transvenous obliteration of gastric varices in liver transplant recipients: A multi-institutional study.
    Saad WE; Chick JFB; Srinivasa RN; Saad N; Kim S; Fischman A; Frey G; Al-Osaimi A; Caldwell S
    Diagn Interv Imaging; 2017 Nov; 98(11):801-808. PubMed ID: 28416166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.
    Choi YH; Yoon CJ; Park JH; Chung JW; Kwon JW; Choi GM
    Korean J Radiol; 2003; 4(2):109-16. PubMed ID: 12845306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical usefulness of balloon occluded retrograde transvenous obliteration in gastric variceal bleeding].
    Kim ES; Park SY; Kwon KT; Lee DS; Park MJ; Chung IK; Park JH; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YW; Seong CK
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):315-23. PubMed ID: 14695698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and post-balloon-occluded retrograde transvenous obliteration clinical evaluation, management, and imaging: indications, management protocols, and follow-up.
    Saad WE; Al-Osaimi AM; Caldwell SH
    Tech Vasc Interv Radiol; 2012 Sep; 15(3):165-202. PubMed ID: 23021831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.
    Ferral H; Gamboa P; Postoak DW; Albernaz VS; Young CR; Speeg KV; McMahan CA
    Radiology; 2004 Apr; 231(1):231-6. PubMed ID: 14990811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration.
    Hong CH; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Hong HP; Shin JH
    J Gastroenterol Hepatol; 2009 Mar; 24(3):372-8. PubMed ID: 19032446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation.
    Cho SK; Shin SW; Yoo EY; Do YS; Park KB; Choo SW; Han H; Choo IW
    Korean J Radiol; 2007; 8(6):520-30. PubMed ID: 18071283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency balloon-occluded retrograde transvenous obliteration of ruptured gastric varices.
    Sonomura T; Ono W; Sato M; Sahara S; Nakata K; Sanda H; Kawai N; Minamiguchi H; Nakai M; Kishi K
    World J Gastroenterol; 2013 Aug; 19(31):5125-30. PubMed ID: 23964147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.